Search

everythinglearnresearchcommunity

for

Search:↓

Rezpegaldesleukin shows promise for treating severe alopecia areata.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Eclipta alba IIHR Sel EA 43 is best for large-scale cultivation due to high growth, yield, and wedelolactone content.

Leucaena was unpalatable, caused health issues, and reduced fertility in heifers.

Feeding steers only Leucaena leucocephala causes severe health issues and poor weight gain.

Leonuri Herba alkaloids may help treat hormone-induced enlarged prostate in rats.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Eclipta alba may improve memory and help treat Alzheimer's disease.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Wedelolactone may help treat chronic diseases due to its strong antioxidant properties.

Eclipta alba can effectively kill worms like the drug Albendazole.

PLD is an effective and safer alternative for treating breast cancer.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Ritlecitinib is safe and may effectively treat alopecia areata.

Using a special laser and skin medication together successfully cleared a skin condition in a pregnant woman.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.